Figure 2.
A: Effect of ranolazine on HbA1c by visit. B: Effect of ranolazine on proportion of subjects achieving HbA1c <7.0%. Placebo, n = 229; ranolazine, n = 227. *P = 0.0046 vs. placebo. †P < 0.0001 vs. placebo. ‡P = 0.0004 vs. placebo.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.